Cite

1. Colunga Biancatelli RM, Congedo V, Calvosa L, Ciacciarelli M, Polidoro A, Iuliano L. Adverse reactions of Amiodarone. J Geriatr Cardiol 2019; 16(7): 552-66.10.1155/2019/3418950 Search in Google Scholar

2. Seki S, Kobayashi M, Itagaki S, Hirano T, Iseki K. Contribution of organic anion transporting polypeptide OATP2B1 to amiodarone accumulation in lung epithelial cells. Biochim Biophys Acta 2009; 1788(5): 911-7.10.1016/j.bbamem.2009.03.00319285480 Search in Google Scholar

3. Natale A, Boeckmans J, Desmae T, De Boe V, De Kock J, Vanhaecke T, et al. Hepatic cells derived from human skin progenitors show a typical phospholipidotic response upon exposure to amiodarone. Toxicol Lett 2018; 284: 184-94.10.1016/j.toxlet.2017.11.01429248575 Search in Google Scholar

4. Prill S, Bavli D, Levy G, Ezra E, Schmälzlin E, Jaeger MS, et al. Real-time monitoring of oxygen uptake in hepatic bioreactor shows CYP450-independent mitochondrial toxicity of acetaminophen and amiodarone. Arch Toxicol 2016; 90(5): 1181-91.10.1007/s00204-015-1537-226041127 Search in Google Scholar

5. Serviddio G, Bellanti F, Giudetti AM, Gnoni GV, Capitanio N, Tamborra R, et al. Mitochondrial oxidative stress and respiratory chain dysfunction account for liver toxicity during amiodarone but not dronedarone administration. Free Radic Biol Med 2011; 51(12): 2234-42.10.1016/j.freeradbiomed.2011.09.00421971348 Search in Google Scholar

6. Zaeemzadeh N, Hemmati A, Arzi A, Jalali M, Rashidi I.Protective effect of caffeic acid phenethyl ester (CAPE) on amiodarone-induced pulmonary fibrosisin rat. Iran J Pharm Res 2011; 10(2): 321-8. Search in Google Scholar

7. Trivier JM, Pommery N, Lhermitte M. Antioxidant defense capacity modulation of two human cell lines by amiodarone and desethylamiodarone. Toxicol In Vitro 1997; 11(3): 209-16.10.1016/S0887-2333(97)00008-8 Search in Google Scholar

8. Pollak PT, Sharma AD, Carruthers SG. Relation of amiodarone hepatic and pulmonary toxicity to serum drug concentrations and superoxide dismutase activity. Am J Cardiol 1990; 65(18): 1185-91.10.1016/0002-9149(90)90971-32337027 Search in Google Scholar

9. Wang Y, Branicky R, Noe A, Hekimi S. Superoxide dismutases: Dual roles in controlling ROS damage and regulating ROS signaling. J Cell Biol 2018; 217(6): 1915-28.10.1083/jcb.201708007598771629669742 Search in Google Scholar

10. Miao L, St Clair DK. Regulation of superoxide dismutase genes: implications in disease. Free Radic Biol Med 2009; 47(4): 344-56.10.1016/j.freeradbiomed.2009.05.018273157419477268 Search in Google Scholar

11. Russmann S, Jetter A, Kullak-Ublick GA. Pharmacogenetics of drug-induced liver injury. Hepatology 2010; 52(2): 748-61.10.1002/hep.2372020607838 Search in Google Scholar

12. Huang YS, Su WJ, Huang YH, Chen CY, Chang FY, Lin HC, et al. Genetic polymorphisms of manganese superoxide dismutase, NAD(P)H:quinone oxidoreductase, glutathione S-transferase M1 and T1, and the susceptibility to drug-induced liver injury. J Hepatol 2007; 47(1): 128–34.10.1016/j.jhep.2007.02.00917400324 Search in Google Scholar

13. Lucena MI, Garcia-Martin E, Andrade RJ, Martinez C, Stephens C, Ruiz JD, et al. Mitochondrial superoxide dismutase and glutathione peroxidase in idiosyncratic drug-induced liver injury. Hepatology 2010; 52(1): 303-12.10.1002/hep.2366820578157 Search in Google Scholar

14. Alachkar H, Fulton N, Sanford B, Malnassy G, Mutonga M, Larson RA, et al. Expression and polymorphism (rs4880) of mitochondrial superoxide dismutase (SOD2) and asparaginase induced hepatotoxicity in adult patients with acute lymphoblastic leukemia. Pharmacogenomics J 2017; 17(3): 274-9.10.1038/tpj.2016.7508992027019981 Search in Google Scholar

15. Tokushige K, Hashimoto E, Noto H, Yatsuji S, Tobari M, Torii N, et al. Clinical significance of serum ornithine carbamoyltransferase in patients with non-alcoholic steatohepatitis. Hepatol Res 2009; 39(9): 939–43.10.1111/j.1872-034X.2009.00530.x19712272 Search in Google Scholar

16. Lalisang TJ. Serum bile acid: an alternative liver function marker in the obstructive jaundice patient. Acta Med Indones 2012; 44(3): 233-8. Search in Google Scholar

17. Pachkoria K, Lucena MI, Ruiz-Cabello F, Crespo E, Cabello MR, Andrade RJ. Genetic polymorphisms of CYP2C9 and CYP2C19 are not related to drug-induced idiosyncratic liver injury (DILI). Br J Pharmacol 2007; 150(6): 808-15.10.1038/sj.bjp.0707122201385917279092 Search in Google Scholar

18. Teschke R, Wolff A, Frenzel C, Schwarzenboeck A, Schulze J, Eickhoff A. Drug and herb induced liver injury: Council for International Organizations of Medical Sciences scale for causality assessment. World J Hepatol 2014; 6(1): 17‒32.10.4254/wjh.v6.i1.17395380824653791 Search in Google Scholar

19. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40(5): 373‒83.10.1016/0021-9681(87)90171-83558716 Search in Google Scholar

20. Dupont WD, Plummer WD Jr. Power and sample size calculations. A review and computer program. Control Clin Trials 1990; 11(2): 116-28.10.1016/0197-2456(90)90005-M Search in Google Scholar

21. Jovanovic D, Milovanovic DR, Jeremic N, Nikolic T, Stojic I, Jakovljevic V, et al. Oxidative stress parameters after abdominal hysterectomy and their relationships with quality of recovery. Ser J Exp Clin Res 2019; 20(2): 27-36.10.1515/sjecr-2017-0046 Search in Google Scholar

22. Bresciani G, da Cruz IB, González-Gallego J. Manganese superoxide dismutase and oxidative stress modulation. Adv Clin Chem 2015; 68: 87-130.10.1016/bs.acc.2014.11.00125858870 Search in Google Scholar

23. Barbisan F, Motta Jde R, Trott A, Azzolin V, Dornelles EB, Marcon M, et al. Methotrexate-related response on human peripheral blood mononuclear cells may be modulated by the Ala16Val-SOD2 gene polymorphism. PLoS One 2014; 9(10): e107299.10.1371/journal.pone.0107299420367625330300 Search in Google Scholar

24. Duarte T, da Cruz IB, Barbisan F, Capelleto D, Mo-resco RN, Duarte MM. The effects of rosuvastatin on lipidlowering, inflammatory, antioxidant and fibri-nolytics blood biomarkers are influenced by Val16Ala superoxide dismutase manganese-dependent gene polymorphism. Pharmacogenomics J 2016; 16(6): 501-6.10.1038/tpj.2015.9126882122 Search in Google Scholar

25. Sutton A, Khoury H, Prip-Buus C, Cepanec C, Pessayre D, Degoul F. The Ala16Val genetic dimorphism modulates the import of human manganese superoxide dismutase into rat liver mitochondria. Pharmacogenetics 2003; 13(3): 145–57.10.1097/00008571-200303000-00004 Search in Google Scholar

26. Sutton A, Imbert A, Igoudjil A, Descatoire V, Cazanave S, Pessayre D, et al. The manganese superoxide dismutase Ala16Val dimorphism modulates both mitochondrial import and mRNA stability. Pharmacogenet Genomics 2005; 15(5): 311-9.10.1097/01213011-200505000-0000615864132 Search in Google Scholar

27. Caple F, Williams EA, Spiers A, Tyson J, Burtle B, Daly AK, et al. Inter-individual variation in DNA damage and base excision repair in young, healthy non-smokers: effects of dietary supplementation and genotype. Br J Nutr 2010; 103(11): 1585-93.10.1017/S000711450999354020082738 Search in Google Scholar

28. Bursac-Mitrovic M, Milovanovic DR, Mitic R, Jovanovic D, Sovrlic M, Vasiljevic P, et al. Effects of L-ascorbic acid and alpha-tocopherol on biochemical parameters of swimming-induced oxidative stress in serum of guinea pigs. Afr J Tradit Complement Altern Med 2016; 13(4): 29-33.10.21010/ajtcam.v13i4.5556615028852717 Search in Google Scholar

29. Pavlovic DM, Markisic MS, Pavlovic AM. Vitamin C in neuropsychiatry. Ser J Exp Clin Res 2015; 16(2): 157-61.10.1515/sjecr-2015-0021 Search in Google Scholar

30. Montano MA, da Cruz IB, Duarte MM, Krewer Cda C, da Rocha MI, Mânica-Cattani MF, et al. Inflammatory cytokines in vitro production are associated with Ala16Val superoxide dismutase gene polymorphism of peripheral blood mononuclear cells. Cytokine 2012; 60(1): 30-3.10.1016/j.cyto.2012.05.02222688013 Search in Google Scholar

31. Bastaki M, Huen K, Manzanillo P, Chande N, Chen C, Balmes JR, et al. Genotype-activity relationship for Mnsuperoxide dismutase, glutathione peroxidase 1 and catalase in humans. Pharmacogenet Genomics 2006; 16(4): 279-86.10.1097/01.fpc.0000199498.08725.9c16538174 Search in Google Scholar

32. Redensek S, Flisar D, Kojovic M, Kramberger MG, Georgiev D, Pirtosek Z, et al. Genetic variability of inflammation and oxidative stress genes does not play a major role in the occurrence of adverse events of dopaminergic treatment in Parkinson’s disease. J Neuroinflammation 2019; 16(1): 50.10.1186/s12974-019-1439-y639398230813952 Search in Google Scholar

33. Souza RP, Tampakeras M, Basile V, Shinkai T, Rosa DV, Potkin S, et al. Lack of association of GPX1 and MnSOD genes with symptom severity and response to clozapine treatment in schizophrenia subjects. Hum Psychopharmacol 2009; 24(8): 676-9.10.1002/hup.107619946932 Search in Google Scholar

34. Jovanovic J, Milovanovic DR, Sazdanovic P, Sazdanovic M, Radovanović M, Novković Lj, et al. Factors profile for liver damage in cardiac inpatients. Vojnosanitet Pregl 2019; OnLine-First (00): 171-171. doi: 10.2298/VSP180702171J. Open DOISearch in Google Scholar

35. Dragicevic B, Suvakov S, Jerotic D, Reljic Z, Djukanovic L, Zelen I, et al. Association of SOD2 (rs4880) and GPX1 (rs1050450) Gene Polymorphisms with Risk of Balkan Endemic Nephropathy and its Related Tumors. Medicina (Kaunas) 2019; 55(8). pii: E435.10.3390/medicina55080435672389631382611 Search in Google Scholar

36. Jerotic D, Matic M, Suvakov S, Vucicevic K, Damjanovic T, Savic-Radojevic A, et al. Association of Nrf2, SOD2 and GPX1 Polymorphisms with Biomarkers of Oxidative Distress and Survival in End-Stage Renal Disease Patients. Toxins (Basel) 2019; 11(7). pii: E431.10.3390/toxins11070431666973431340563 Search in Google Scholar

37. Despotovic M, Stoimenov TJ, Stankovic I, Pavlovic D, Sokolovic D, Cvetkovic T, et al. Gene polymorphisms of tumor necrosis factor alpha and antioxidant enzymes in bronchial asthma. Adv Clin Exp Med 2015; 24(2): 251-6.10.17219/acem/4045425931357 Search in Google Scholar

eISSN:
2335-075X
ISSN:
1820-8665
Language:
English
Publication timeframe:
4 times per year
Journal Subjects:
Medicine, Clinical Medicine, other